Hando T, Sugimori H, Higashiiwai H, Kuroshima Y, Nishiya I, Sugimoto O, Noda K
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Nov;37(11):2287-90.
In this paper, we analyzed the results obtained in a mass survey using mobile units. The survey covered 276,846 women of whrom 78,018 (24.6%) were women who were being screened for the first time and the other 208,828 had been screened previously. 1) The total detection rate was 0.04% for invasive cancer, 0.03% for carcinoma in situ and 0.06% for severe dysplasia of the uterine cervix. The prevalence rate for 1,000 women was calculated as 0.40, 0.30 and 0.63 respectively. 2) The detection rate for invasive cancer, carcinoma in situ and severe dysplasia was 0.08%, 0.07% and 0.08% respectively for women who were being screened for the first time and 0.03%, 0.02% and 0.06% respectively for repeats. Through the latter results, the incidence rate for 100,000 women was calculated as 30 for invasive cancer, 20 for carcinoma in situ and 60 for severe dysplasia. 3) The detection rate for invasive cancer and severe dysplasia increased abruptly above 60 years and that for carcinoma in situ at 65 years old and over. 4) The detection rate for invasive cancer, carcinoma in situ and severe dysplasia in previously screened women showed little fluctuation by age group.
在本文中,我们分析了使用移动设备进行大规模调查所获得的结果。该调查涵盖了276,846名女性,其中78,018名(24.6%)是首次接受筛查的女性,另外208,828名曾接受过筛查。1)浸润性癌的总检出率为0.04%,原位癌为0.03%,子宫颈重度发育异常为0.06%。每1000名女性的患病率分别计算为0.40、0.30和0.63。2)首次接受筛查的女性中,浸润性癌、原位癌和重度发育异常的检出率分别为0.08%、0.07%和0.08%,再次筛查的女性分别为0.03%、0.02%和0.06%。根据后一组结果,每10万名女性中浸润性癌的发病率计算为30,原位癌为20,重度发育异常为60。3)浸润性癌和重度发育异常的检出率在60岁以上急剧上升,原位癌在65岁及以上急剧上升。4)曾接受过筛查的女性中,浸润性癌、原位癌和重度发育异常的检出率在各年龄组中波动较小。